EUCTR2004-001512-31-ESActive, not recruitingNot Applicable
Evaluación del efecto de AM3 en el tratamiento de la cistitis recidivante de la mujer
Industial Farmacéutica Cantabria S. A.0 sitesStarted: September 20, 2004Last updated:
Conditions
Drugs
Trial Snapshot
- Phase
- Not Applicable
- Status
- Active, not recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional clinical trial of medicinal product
Eligibility Criteria
- Sex
- Female
Inclusion Criteria
- •Women with aged between 18-75
- •Actual diagnosis of recurrent cystitis confirmed with positive urinalysis
- •Two or more previous cystitis episodies in the last 6 months or three ore more in te last year (diagnosis in urinalysis of more than 1.000 UFC/ml ) treated with antibiotics.
- •Negative pregnancy test
- •Adoption of contraceptives devices
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
Exclusion Criteria
- •Bladder lithiasis
- •Infectious lithiasis
- •Low bladder obstruction
- •Bladder ureteral flow
- •Infection of high urinary tract (pyelonephritis)
- •Disturbances of the bladder-urethral anatomy
- •Disturbances of the bladder-urethral fuction
- •Feverish urinary infection
- •Breast -feading period
Investigators
Similar Trials
Not yet recruiting
Phase 4
A study to assess the effectiveness of 2 dressings in managing the diabetic foot woundsCTRI/2024/05/068228Shahala Shirin T P
Active, not recruiting
Not Applicable
SO03-01 - EVALUATION OF THE EFFECT OF N-3 SUPPLEMENTATION ON FUNCTIONAL IMPROVEMENT IN POSTSTROKE PATIENTS - SO3-01Post ischemic strokeEUCTR2009-014730-22-ITFONDAZIONE SALVATORE MAUGERI - CLINICA DEL LAVORO E DELLA RIABILITAZIONE
Active, not recruiting
Phase 1
Efficacy and Safety of AM-111 in the Treatment of Acute InnerEar Hearing LossEUCTR2013-002077-21-CZAuris Medical AG255
Active, not recruiting
Phase 1
Efficacy and Safety of AM-111 in the Treatment of Acute InnerEar Hearing LossEUCTR2013-002077-21-HUAuris Medical AG255
Active, not recruiting
Phase 1
Efficacy and Safety of AM-111 in the Treatment of Acute InnerEar Hearing LossIdiopathic sudden sensorineural hearing lossMedDRA version: 19.1Level: PTClassification code 10043882Term: TinnitusSystem Organ Class: 10013993 - Ear and labyrinth disordersEUCTR2013-002077-21-DEAuris Medical AG255